-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Guangxiang Pharmaceutical of Shijiazhuang Sihua Pharmaceutical Group Passes the Reassessment for “Provincial-Level Single-Champion Manufacturing Enterprise”
Category:
发布时间：2025-09-11
【概要描述】
Recently, the Hebei Provincial Department of Industry and Information Technology released the seventh batch of Hebei Province’s Manufacturing Single-Champion Enterprises, as well as the fourth batch of provincially recognized Manufacturing Single-Champion Enterprises that have passed re-examination, among which metronidazole produced by Hebei Guangxiang Pharmaceutical Co., Ltd. of Shijiazhuang Sihua Pharmaceutical Group has been approved upon re-examination.
Recently, the Hebei Provincial Department of Industry and Information Technology released the seventh batch of Hebei Province’s Manufacturing Single-Champion Enterprises, as well as the fourth batch of provincially recognized Manufacturing Single-Champion Enterprises that have passed re-examination, among which metronidazole produced by Hebei Guangxiang Pharmaceutical Co., Ltd. of Shijiazhuang Sihua Pharmaceutical Group has been re-certified.
According to reports, provincial “Single-Champion” manufacturing enterprises are those that have long been focused on specific niche segments of the manufacturing industry, with production technologies or process capabilities reaching internationally advanced and domestically leading levels, and whose market share for a single product (or productive service) ranks among the top globally or nationally. Such enterprises belong to Hebei Province’s key pillar industries and specialized industries; they participate in the construction of major national and provincial innovation platforms, in initiatives to strengthen and supplement industrial chains in the manufacturing sector, and in “challenge-based recruitment” projects aimed at overcoming critical bottleneck technologies; moreover, they play a pivotal role within advanced manufacturing industry clusters. These enterprises will be given priority in the nomination and application process.
The head of Guangxiang Pharmaceutical stated, “Our next step will be to aim for a new model of industrialization, continuously advance the initiative to cultivate high-quality enterprises, further benchmark against leading companies, refine our tiered enterprise-development system, steadily expand both domestic and international markets, accelerate our transformation into a national manufacturing single-champion enterprise, and thereby contribute to the Group’s high-quality development.”
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091